Abstract |
We have previously demonstrated that semimature dendritic cell- (smDC-) based immunotherapy is effective for the treatment of collagen-induced arthritis (CIA) prior to disease onset. In the present study, we examined the efficacy of combination therapy with smDCs and methotrexate (MTX) in advanced CIA with a score of 2-3. Combination therapy with low-dose MTX and type II collagen- (CII-) pulsed smDCs (CII-smDCs) was more effective in inhibiting disease progression than high or low-dose MTX alone or a combination of high dose MTX and CII-smDCs. The effect of CII-smDCs alone was also comparable to the combination therapy. CD4(+)Foxp3(+) Treg populations and IL-10 secretion markedly increased, and CII-specific autoreactive T cells decreased in mice treated with CII-smDCs alone or in combination with MTX. Combination therapy reduced the secretion of interferon-γ (IFN-γ) and IL-17 with little influence on the IL-4 secretion in the mixed leukocyte reaction. These results imply that the combination therapy with low-dose MTX and smDCs is effective in controlling advanced CIA by enhancing Treg population and suppresses antigen-specific Th1/Th17 immunity, rather than initiating Th1 to Th2 immune deviation. Our findings provide a better understanding of the DC therapy in combination with MTX for the treatment of patients with rheumatoid arthritis (RA).
|
Authors | Jun-Eui Park, Jinah Jang, Ji-Hye Choi, Mi-Sun Kang, Yun-Ju Woo, Young-Rim Seong, Chan-Bum Choi, Hye-Soon Lee, Sang-Cheol Bae, Yong-Soo Bae |
Journal | Journal of immunology research
(J Immunol Res)
Vol. 2015
Pg. 834085
( 2015)
ISSN: 2314-7156 [Electronic] Egypt |
PMID | 26221616
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Surface
- Immunosuppressive Agents
- Methotrexate
|
Topics |
- Animals
- Antigens, Surface
(metabolism)
- Arthritis, Experimental
(immunology, metabolism, pathology, therapy)
- Coculture Techniques
- Dendritic Cells
(immunology, metabolism)
- Disease Models, Animal
- Female
- Immune Tolerance
- Immunophenotyping
- Immunosuppression Therapy
- Immunosuppressive Agents
(administration & dosage)
- Immunotherapy, Adoptive
- Lymphoid Tissue
(immunology, metabolism)
- Methotrexate
(administration & dosage)
- Mice
- Phenotype
- T-Lymphocytes, Regulatory
(immunology, metabolism)
- Th1 Cells
(immunology, metabolism)
- Th17 Cells
(immunology, metabolism)
|